BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Session Board//Session Board//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:153226-20260302T153000Z@medtrade.com
DTSTAMP:20260603T170613Z
DTSTART:20260302T153000Z
DTEND:20260302T170000Z
SUMMARY:LEG02: M&amp\;A Considerations in Avoiding Government Enforcement Action
DESCRIPTION:When engaging in mergers and acquisitions (M&amp\;A) in the healthcare sector\, careful attention to regulatory compliance is essential to avoid enforcement actions. Key considerations include thorough due diligence to uncover potential violations of healthcare laws such as the Anti-Kickback Statute\, Stark Law\, and HIPAA. Parties must evaluate the target’s billing practices\, licensure status\, and any history of audits or investigations. Ensuring compliance with federal and state fraud and abuse laws is critical\, as even inadvertent violations can lead to significant penalties\, transaction delays\, and materially impact valuation. Awareness of emerging state disclosure requirements for private equity investments is becoming increasingly important. Structuring deals to address identified risks—such as through indemnifications or compliance plans—is also recommended. Post-closing integration should include alignment of compliance programs and staff training. Involving legal and compliance professionals early helps mitigate risk and supports a smoother transition. Ultimately\, proactive regulatory planning throughout the M&amp\;A process protects both the acquiring and acquired entities from potential enforcement exposure and ensures long-term operational success.
LOCATION:124 B
END:VEVENT
END:VCALENDAR